Microbiology: Bacteria, Viruses, and Fungi

Microbiology on Step 1 rewards a small number of classification frameworks applied over and over. Rather than memorizing every organism in isolation, learn to sort microbes by structure, then reason about how that structure drives disease and how drugs interrupt it. The categories below convert a huge subject into a predictable set of decisions.

Core Idea

• Structure predicts everything. Gram reaction, shape, oxygen requirement, and envelope status each narrow the differential and point toward the mechanism of disease and the vulnerable drug target.
• Virulence is about evasion and damage. Capsules hide organisms from the immune system; toxins and cell-wall components cause the actual injury and the clinical syndrome.
• Drugs win by hitting a target the microbe cannot easily replace, and resistance is simply the organism finding a workaround for that target.

Bacterial Classification

Sort every bacterium along a few axes:

• Gram-positive vs. Gram-negative. Gram-positives have a thick peptidoglycan wall that retains crystal violet (stains purple). Gram-negatives have a thin wall plus an outer membrane containing lipopolysaccharide (LPS) and stain pink. The outer membrane is a permeability barrier that makes many Gram-negatives intrinsically harder to treat.
• Shape. Cocci (spheres) vs. rods/bacilli; arrangements such as clusters or chains further subdivide the cocci.
• Oxygen requirement. Obligate aerobes need oxygen; obligate anaerobes are poisoned by it (they lack catalase/superoxide dismutase); facultative organisms grow either way. Anaerobes tend to dominate deep, closed, or necrotic spaces where oxygen is scarce.

Bacterial Structure and Virulence

• Capsule. A polysaccharide coat that blocks phagocytosis; it is a leading virulence factor for organisms that cause meningitis and pneumonia, and it is the target of many vaccines (conjugation to protein improves the response in children).
• Endotoxin (LPS). A structural component of the Gram-negative outer membrane. It is released on lysis, is heat-stable, and triggers a strong innate immune (fever, hypotension, septic shock) response through the lipid A moiety. It is not secreted and cannot be converted into a vaccine toxoid.
• Exotoxin. A secreted protein made by Gram-positive and Gram-negative bacteria. Exotoxins are highly specific, often extremely potent, frequently heat-labile, and can be inactivated into toxoids for vaccines. Conceptually they act by mechanisms such as enzymatic inactivation of host targets, superantigen activation, or membrane damage.

High-yield pathogen categories to think in: encapsulated organisms (immune evasion), toxin-producers (protein-synthesis or signaling disruption), intracellular organisms (hide from antibodies), and spore-formers (environmental survival).

Viruses: Classification and Replication

• Genome. DNA vs. RNA is the first split; then single- vs. double-stranded and, for RNA, positive-sense (directly translatable, acts like mRNA) vs. negative-sense (must carry its own polymerase).
• Envelope. Enveloped viruses acquire a lipid membrane from the host and are fragile in the environment, favoring transmission by close contact, blood, or secretions. Naked (non-enveloped) viruses are stable and resist drying, acid, and detergents, favoring fecal-oral spread.
• Replication basics. Most DNA viruses replicate in the nucleus using host machinery; most RNA viruses replicate in the cytoplasm. Retroviruses use reverse transcriptase to make DNA from RNA and integrate into the host genome, a step unique enough to be a drug target.

Fungi and Parasites (Conceptual)

• Fungi. Grouped as yeasts (single cells that bud), molds (filamentous hyphae), and dimorphic fungi (mold in the environment, yeast at body temperature). Their ergosterol membrane and chitin wall are exploited by antifungals. Opportunistic fungal disease clusters in immunocompromised hosts.
• Parasites. Split into protozoa (single-celled) and helminths (worms). Categories track transmission (fecal-oral, vector-borne, tissue invasion) and are keyed to exposure history and host immune status.

Antimicrobial Mechanisms and Resistance

Group drugs by the target they attack, not by name:

• Cell wall synthesis — blocks peptidoglycan cross-linking, so it works only on growing bacteria and spares human cells (which have no wall).
• Protein synthesis — targets the bacterial ribosome, whose subunits differ from the human ribosome, providing selective toxicity.
• Nucleic acid / folate — inhibits DNA replication enzymes or the folate pathway bacteria must build themselves.

Resistance arises by enzymatic drug inactivation, target modification (altered binding site), decreased uptake or increased efflux, and bypass pathways. These mechanisms spread rapidly because bacteria share resistance genes on plasmids through horizontal transfer.

High-Yield Exam Patterns

• A vignette with fever, hypotension, and Gram-negative sepsis is pointing you at LPS/endotoxin and lipid A.
• If the stem stresses a specific, potent, protein-mediated effect that a toxoid vaccine could prevent, think exotoxin, not endotoxin.
• Capsule is the answer whenever immune evasion or anti-phagocytosis is described, especially in asplenic patients.
• Naked virus + fecal-oral + environmentally stable travel together; enveloped + close contact + fragile travel together.
• When asked why a drug spares human cells, name the absent or different target (cell wall, unique ribosome, self-made folate).
• Plasmid-mediated transfer is the usual explanation for rapidly spreading resistance across species.

Common Traps to Avoid

• Assuming only Gram-negatives make toxins — Gram-positives are prolific exotoxin producers.
• Confusing endotoxin (structural, heat-stable, LPS) with exotoxin (secreted, often heat-labile, toxoid-able).
• Believing all DNA viruses are enveloped or all RNA viruses are naked — envelope status is independent of genome type.
• Treating "anaerobe" as a location clue only; remember it reflects an oxygen-handling enzyme deficiency.
• Calling resistance purely a mutation phenomenon and forgetting horizontal, plasmid-borne gene transfer.